Results 101 to 110 of about 6,841 (192)

Quantification of Hepatitis B Virus Covalently Closed Circular DNA in Infected Cell Culture Models by Quantitative PCR

open access: yesBio-Protocol, 2019
Persistence of the human hepatitis B virus (HBV) requires the maintenance of covalently closed circular (ccc)DNA, the episomal genome reservoir in nuclei of infected hepatocytes.
Bingqian Qu, Stephan Urban
doaj   +1 more source

Image_4_KAT2A Promotes Hepatitis B Virus Transcription and Replication Through Epigenetic Regulation of cccDNA Minichromosome.TIF

open access: yes, 2022
Hepatitis B virus (HBV) infection remains a major health problem worldwide. Sufficient maintenance of the HBV covalently closed circular DNA (cccDNA), which serves as a template for HBV transcription, is responsible for the failure of antiviral therapies.
Ji-Hua Ren (3181890)   +24 more
core   +1 more source

Data_Sheet_1_KAT2A Promotes Hepatitis B Virus Transcription and Replication Through Epigenetic Regulation of cccDNA Minichromosome.PDF

open access: yes, 2022
Hepatitis B virus (HBV) infection remains a major health problem worldwide. Sufficient maintenance of the HBV covalently closed circular DNA (cccDNA), which serves as a template for HBV transcription, is responsible for the failure of antiviral therapies.
Ji-Hua Ren (3181890)   +24 more
core   +1 more source

Effect of APE1 treatment on detection of cccDNA levels in 35 paired CT and CNCT samples.

open access: yes, 2016
The 35 paired HCC samples with detectable cccDNA values (left column, N = 35) were divided into two group according to ratio of cccDNA in the paired CT and CNCT samples (CT/CNCT) 1 (right column, N = 10).
Yanmeng Chen (2839214)   +7 more
core   +1 more source

HBV cccDNA: The Molecular Reservoir of Hepatitis B Persistence and Challenges to Achieve Viral Eradication

open access: yesBiomolecules
Hepatitis B virus (HBV) is a major global health issue, with an estimated 254 million people living with chronic HBV infection worldwide as of 2022. Chronic HBV infection is the leading cause of cirrhosis and liver cancer. Current treatment with nucleos(t)ide analogs is effective in the suppression of viral activity but generally requires lifelong ...
André Boonstra, Gulce Sari
openaire   +3 more sources

CEP290 is Associated With Chromatin Accessibility of Hepatitis B virus cccDNA

open access: yesJournal of Molecular Biology
Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) serves as a stable nuclear template for viral transcription, yet the mechanisms controlling its chromatin accessibility remain poorly understood. Here, we performed single-cell assay for transposase-accessible chromatin sequencing (ATAC-seq) in HBV-infected human hepatocytes to profile ...
Sadahiro Iwabuchi   +7 more
openaire   +2 more sources

Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA

open access: yesViruses
Hepatitis B virus (HBV) can cause chronic infections, significantly increasing the risk of death from cirrhosis and hepatocellular carcinoma (HCC). A key player in chronic HBV infection is covalently closed circular DNA (cccDNA), a stable episomal form ...
Deok-Hwa Seo   +7 more
doaj   +1 more source

Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment

open access: yesThe Journal of Clinical Investigation
The cornerstone of functional cure for chronic hepatitis B (CHB) is hepatitis B surface antigen (HBsAg) loss from blood. HBsAg is encoded by covalently closed circular DNA (cccDNA) and HBV DNA integrated into the host genome (iDNA). Nucleos(t)ide analogs
Maraake Taddese   +15 more
doaj   +1 more source

DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication

open access: yesAdvanced Science
Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) contributes to viral persistence and recurrence, however, how the host innate immune system responds to cccDNA is still less known.
Caiyue Ren   +15 more
doaj   +1 more source

Lipid nanoparticle-encapsulated DOCK11-siRNA efficiently reduces hepatitis B virus cccDNA level in infected mice

open access: yesMolecular Therapy: Methods & Clinical Development
The hepatitis B virus (HBV) infects many people worldwide. As HBV infection frequently leads to liver fibrosis and carcinogenesis, developing anti-HBV therapeutic drugs is urgent.
Hikari Okada   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy